ANEB - Director at Anebulo Pharmaceuticals Acquires Company Stock Options Worth 26097 Shares | Benzinga
Bimal Shah, Director at Anebulo Pharmaceuticals (NASDAQ:ANEB), reported a large acquisition of company stock options on October 11, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Shah, Director at Anebulo Pharmaceuticals, a company in the Health Care sector, was just awarded stock options worth 26,097 shares of ANEB. The options give Shah the right to buy the company's stock at $3.03 per share.
Anebulo Pharmaceuticals shares are trading up 15.61% at $3.48 at the time of this writing on Wednesday morning. Since the current price is $3.48, this makes Shah's 26,097 shares worth $90,817.